What changes should I look out for?
Colin SM, Metcalfe C, Donovan J, Lane JA, Davis M, Neal D, Hamdy
F, Martin RM. Associations of lower urinary tract symptoms with
prostate-specific antigen levels, and screen detected localized and
advanced prostate cancer: a case-control study nested within the UK
based population ProtecT (Prostate testing for cancer and
Treatment) study. BJU Int, 2008, 102 (10):1400-140
Popiolek M, et al. Natural History of Early, Localized Prostate
Cancer: A Final Report from Three Decades of Follow-up. Eur Urol
(2012). Published online 13 October 2012
Johansson J-E, Andren O, Andersson S O, Dickman P W, Holmberg L,
Magnuson A, Adami H O. Natural History of Early Localised Prostate
Cancer, JAMA 2004; 291 (22) 2713-2719
Prostate Cancer Risk Management Programme information for
primary care; PSA testing in asymptomatic men. Evidence document
January 2010
What is an enlarged prostate (benign prostatic
hyperplasia)?
Kaplan ST. Update on the American Urological Association
Guidelines for the Treatment of Benign Prostatic Hyperplasia.
Reviews in Urology. 2006; 8(Supp 4): S10-S17.
Roehrborn CG. BPH progression: concept and key learning from
MTOPS, ALTESS, COMBAT, and ALF-ONE. BJU International. 2008; 101
(supp 3): 17-21.
Trueman P, Hood SC, Nayak US, Mrazek MF. Prevalence of lower
urinary tract symptoms and self-reported diagnosed 'benign
prostatic hyperplasia', and their effect on quality of life in a
community-based survey of men in the UK. BJU Int 1999; 83:
410-415.
Wei JT, Calhoun E, Jacobsen SJ. Urologic diseases in America
project: benign prostatic hyperplasia. Journal of Urology 2005;
173: 1256-1261.
World Cancer Research Fund/American Institute for Cancer. Food,
Nutrition, Physical Activity and the Prevention of Cancer: A Global
Perspective. Washington DC:AICR, 2007
What is prostate cancer?
Cancer Statistics registrations: Registrations of cancer diagnosed
in 2007, England Series MB1 no.38. 2010, London: National
Statistics
ISD Online Northern Ireland Cancer Registry. Cancer Incidence and
Mortality. 2010
Information and Statistics Division, NHS Scotland. 2010 Office for
National Statistics,
Cancer Research UK website:
www.cancerresearchuk.org/cancer-info/cancerstats/types/prostate/incidence.
Accessed October 2012
Family history
Dianat SS, Margreiter M, Eckersberger E, Finkelstein J, Kuehas F,
Herwig R, Ayati M, Lepor H, Djavan B. Gene polymorphisms and
prostate cancer: the evidence 2009 BJUI: 104 1560-1572
Edwards SM, Kote-Jarai Z, Meitz J, Hamoudi R, Hope Q, Osin P,
Jackson R, Southgate C, Singh R, Falconer A, Dearnaley DP,
Ardern-Jones A, Murkin A, Dowe A, Kelly J, Williams S, Oram R,
Stevens M, Teare DM, Ponder BA, Gayther SA,
Easton DF, Eeles RA. Two percent of men with early-onset
prostate cancer harbour germline mutations in the BRCA2 gene. Am J
Hum Genet, 2003, 72(1):1-12.
Elo JP and Visakorpi T. Molecular genetics of prostate
cancer. Ann Med 2001;33(2):130-41
Johns LE, Houlston RS. A systematic review and meta-analysis of
familial prostate cancer risk. BJU International 2003; 91:
789-794.
Mitra AV, Bancroft EK, Barbachano Y, Page EC, Foster CS, Jameson
C, Mitchell G, Lindeman GJ, Stapleton A, Suthers G, Evans DG,
Cruger D, Blanco I, Mercer C, Kirk J, Maehle L, Hodgson S, Walker
L, Izatt L, Douglas F, Tucker K, Eeles RA et al. Targeted prostate
cancer screening in men with mutations in BRCA1 and BRCA2 detects
aggressive prostate cancer: preliminary analysis of the results of
the IMPACT study. BJU Int. 2010 Sep 14.
Thompson D, Easton DF. Cancer Incidence in BRCA1 mutation carriers.
J Natl Cancer Inst, 2002, 94(18):1358-1365.
Ethnicity
Ben-Shlomo Y, Evans S, Ibrahim F, Patel B, Anson K, Chinegwundoh F,
Corbishley C, Dorling D, Thomas B, Gillatt D, Kirby R, Muir G,
Nargund V, Popert R, Metcalfe C, Persad R; PROCESS study group. The
Risk of Prostate Cancer amongst Black Men in the United Kingdom:
The PROCESS Cohort Study. Eur Urol 2008; 53(1):99-105
Hooker S, Hernandez W, Chen H, Robbins C, Torres JB, Ahaghotu C,
Carpten J, Kittles RA. Replication of prostate cancer risk loci on
8q24, 11q13, 17q12, 19q33, and Xp11 in African Americans Prostate
2010 Feb 15;70(3):270-6).
Lavender NA, Benford ML, VanCleave TT, Brock GN, Kittles RA, Moore
JH, Hein DW, Kidd LC. Examination of polymorphic glutathione
S-transferase (GST) genes, tobacco smoking and prostate cancer risk
among Men of African Descent: A case-control study BMC Cancer 2009
9: 397)
Mason TE, Ricks-Santi L, Chen W, Apprey V, Joykutty J, Ahaghotu C,
Kittles R, Bonney G, Dunston GM.Association of CD14 variant with
prostate cancer in African American men Prostate 2010 Feb
15;70(3):262-9)
Metcalfe C, Evans S, Ibrahim F, Patel B, Anson K, Chinegwundoh
F, Corbishley C, Gillatt D, Kirby R, Muir G, Nargund V, Popert R,
Persad R, Ben-Shlomo Y Pathways to diagnosis for black men and
white men found to have prostate cancer: the PROCESS cohort study.
British Journal of Cancer (2008)
National Cancer Intelligent Network. Cancer incidence and survival
by major ethnic group, England, 2002-2006
Wang Y, Ray AM, Johnson EK, Zuhlke KA, Cooney KA, Lange EM.
Evidence for an association between prostate cancer and chromosome
8q24 and 10q11 genetic variants in African American men: The flint
men's health study. Prostate 2010 Aug 17).
Xu J, Kibel AS, Hu JJ, Turner AR, Pruett K, Zheng SL, Sun J, Isaacs
SD, Wiley KE, Kim ST, Hsu FC, Wu W, Torti FM, Walsh PC, Chang BL,
Isaacs WB.Prostate cancer risk associated loci in African Americans
Cancer Epidemiol Markers Prev 2009; 18(7) 2145-49).
Lifestyle
Allen NE, Key TJ, Appleby PN et al. Animal foods, protein,
calcium and prostate cancer risk: the European Prospective
Investigation into Cancer and Nutrition. Br J Cancer. 2008 May
6;98(9):1574-81.
Gao X, LaValley MP, Tucker KL Prospective Studies of dairy product
and calcium intakes and prostate cancer risk: A meta-analysis. J
Natl Cancer Inst. 2005;97(23):1768-77
Giovannucci E, Liu Y, Platz EA, Stampfer MJ, Willett WC. Risk
factors for prostate cancer incidence and progression in the health
professionals follow-up study. Int.J Cancer 2007; 121
(7):1571-8
Ma RW, Chapman K A systematic review of the effect of diet in
prostate cancer prevention and treatment. Journal of Human
Nutrition and Dietetics : the Official Journal of the British
Dietetic Association [2009, 22(3):187-99; quiz 200-2]
Orsini N, Bellocco R, Bottai M, Pagano M, Andersson SO, Johansson
JE, Giovannucci E, Wolk A. A prospective study of lifetime physical
activity and prostate cancer incidence and mortality Br J Cancer.
2009 Dec 1;101(11):1932-8. Epub 2009 Oct 27.
World Cancer Research Fund/American Institute for Cancer. Food,
Nutrition, Physical Activity and the Prevention of Cancer: A Global
Perspective. Washington DC:AICR, 2007
What are the symptoms of prostate cancer?
Crawford E D. Understanding the Epidemiology, Natural
History and Key Pathways Involved in Prostate Cancer. 2009 Urology;
73:5A
Johansson J-E, Andren O, Andersson S O, Dickman P W, Holmberg L,
Magnuson A, Adami H O. Natural History of Early Localised Prostate
Cancer, JAMA 2004; 291 (22) 2713-2719
What will the test results tell me?
NICE. Guideline for management of lower urinary tract symptoms in
men. 2010
Prostate Cancer Risk Management Programme information for primary
care; PSA testing in asymptomatic men. Evidence document January
2010